BP967

Bendroflumethiazide

British Pharmacopoeia (BP) Reference Standard

• Synonym(s): 3-Benzyl-6-trifluoromethyl-7-sulfamoyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide
• Empirical Formula (Hill Notation): C₁₅H₁₄F₃N₃O₄S₂
• CAS Number: 73-48-3
• Molecular Weight: 421.41
• EC Number: 200-800-1
• MDL number: MFCD00078963
• UNSPSC Code: 12352125
• NACRES: NA.24

Properties

• grade: pharmaceutical primary standard
• API family: bendroflumethiazide
• form: solid
• shelf life: limited shelf life, expiry date on the label
• manufacturer/tradename: BP
• application(s): pharmaceutical; pharmaceutical small molecule
• format: neat
• storage temp.: 2-8°C
• SMILES string: NS(=O)(=O)c1cc2c(NC(Cc3ccccc3)NS2(=O)=O)cc1C(F)(F)F
• InChI: 1S/C15H14F3N3O4S2/c16-15(17,18)10-7-11-13(8-12(10)26(19,22)23)27(24,25)21-14(20-11)6-9-4-2-1-3-5-9/h1-5,7-8,14,20-21H,6H2,(H2,19,22,23)
• InChI key: HDWIHXWEUNVBIY-UHFFFAOYSA-N
• Gene Information: human ... SLC12A3(6559)

Description

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Bendroflumethiazide BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:

Bendroflumethiazide Tablets

Bendroflumethiazide Oral Suspension

Packaging

Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

Other Notes

Sales restrictions may apply.

Safety Information

• Storage Class Code: 11 - Combustible Solids
• WGK: WGK 2
• Flash Point(F): Not applicable
• Flash Point(C): Not applicable